Applications of nanomaterials in anti‐VEGF treatment for ophthalmic diseases
Journal of Biomedical Materials Research Part A · 2024
DOI: 10.1002/jbm.a.37626 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Biomedical Materials Research Part A, 2024. Verfasst von Lu Teng und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Bethune Hospital of Jilin University, Jilin, China. Hauptthemen laut MEDLINE: Choroidal Neovascularization, Diabetic Retinopathy, Macular Degeneration. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: Natural Science Foundation of Jilin Province, Jilin University.
Abstract (Originalsprache)
Angiogenesis has been determined to be essential in the occurrence and metastasis of diabetic retinopathy (DR), age‐related macular degeneration (AMD), retinal vein occlusion (RVO), choroidal neovascularization (CNV), retinopathy of prematurity (ROP), tumor, etc. However, the clinical use of anti‐vascular endothelial growth factors (VEGF) drugs is currently limited due to its high cost, potential side effects, and need for repeated injections. In recent years, nanotechnology has shown promising results in inhibiting neovascularization and reducing reactive oxygen species (ROS) or inflammatory factors. Some nanomaterials can also act as vehicles for drug delivery, such as lipid nanoparticles and PLGA. The process of angiogenesis and its molecular mechanism are discussed in this article. At the same time, this study aims to systematically review the research progress of nanotechnology and offer more treatment options for neovascularization‐related diseases in clinical ophthalmology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Bethune Hospital of Jilin University, Jilin, China.
Förderung
- Natural Science Foundation of Jilin Province
- Jilin University
Zitieren
APA
Teng, L., Sun, Y., Teng, S., & Hui, P. (2024). Applications of nanomaterials in anti‐VEGF treatment for ophthalmic diseases. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.37626
Vancouver
Teng L, Sun Y, Teng S, Hui P. Applications of nanomaterials in anti‐VEGF treatment for ophthalmic diseases. Journal of Biomedical Materials Research Part A. 2024. doi:10.1002/jbm.a.37626
BibTeX
@article{Teng2024,
author = {Teng, Lu and Sun, Yabin and Teng, Siying and Hui, Peng},
title = {Applications of nanomaterials in anti‐VEGF treatment for ophthalmic diseases},
journal = {Journal of Biomedical Materials Research Part A},
year = {2024},
doi = {10.1002/jbm.a.37626}
}
EUVIMED